JOURNAL FOR IMMUNOTHERAPY OF CANCER PubMed SCIE 中科院1区 JCR:Q1 发文量 8,575 被引量 81,217 影响因子(2023) 2.982主办单位: BMJ PUBLISHING GROUP 出版周期: 连续出版 创刊时间: 2013年 收录汇总 栏目浏览 期刊详情 收录汇总 期刊详情 全息分析 ...
通过分析Journal for ImmunoTherapy of Cancer的IF值、Sitescore值、年度发文量、审稿周期、投稿录用率等指标,综合判断Journal for ImmunoTherapy of Cancer这本刊物的学术权威性及其投稿难度,以帮助你快速了解Journal for ImmunoTherapy of Cancer是top期刊吗、自引率高
通过对比Journal for ImmunoTherapy of Cancer研究方向有哪些、投稿要求影响因子分值、sitescore值、审稿周期、投稿录用率等指标,以图表的形式直观展现Journal for ImmunoTherapy of Cancer研究方向有哪些、投稿要求各个指标的对比趋势图,让您一目了然的看到各个期刊的优缺点,快速锁定目标期刊进行投稿,节省投稿周期!
通过对比Journal for ImmunoTherapy of Cancer投稿过程、梅斯影响因子影响因子分值、sitescore值、审稿周期、投稿录用率等指标,以图表的形式直观展现Journal for ImmunoTherapy of Cancer投稿过程、梅斯影响因子各个指标的对比趋势图,让您一目了然的看到各个期刊的优缺点,快速锁定目标期刊进行投稿,节省投稿周期!
今日期刊解析:European Journal of Nuclear Medicine and Molecular Imaging 简称EJNMMI 创刊时间:1976 出版国家:德国 出版商:Springer Berlin Heidelberg ISSN:1619-7070E-ISSN:1619-7089 EJNMMI前几年的影响因子在7左右,2021年影响因子为10.057!目前即时因子为8.89,预测2022年影响因子在10.38左右,2022年中科院最新分区:1...
近日,复宏汉霖H药 汉斯状®(斯鲁利单抗)针对微卫星高度不稳定(MSI-H)实体瘤开展的II期临床研究数据发表于知名期刊British Journal of Cancer(影响因子:9.075)。研究结果显示,H药在标准治疗失败的MSI-H实体瘤患者中展现出持久的抗肿瘤...
Psychological Influence of Cancer Diagnosis in Patients Attending a Tertiary... Complications of Suppurative Otitis Media - A Retrospective Study in a Tertiary... The Predictors of Growth Response to Growth Hormone Therapy in Growth Hormone... First Professional Pharm D Students' Inspiration to Join ...
Live bacterial therapeutics is gaining attention, especially for cancer therapy, because anaerobic bacteria selectively grow inside the solid tumours. However, the effect of tumour structure and bacterial characteristics on the pharmacokinetics of tumours is unclear; therefore, we aimed to elucidate the ef...
摘要:Metastatic pancreatic cancer(MPC) is one of the most aggressive malignancies, known to be chemo-resistant and have been recently considered resistant to some targeted therapies(TT). Erlotinib combined to gemcitabine is the only targeted therapy that showed an overall survival benefit in MPC. Ne...
The intra-tumoral microbiome as a potential biomarker of response to external beam radiation therapy in cervical cancer We aimed to determine the potential predictive value of the intra-tumoral microbiome as a marker of the response to external beam radiation therapy (EBRT) in cervical cancer (CC)...